Spurned By NICE On Avastin In Bowel Cancer, Roche Looks To U.K. Cancer Drugs Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
NICE's definitive decision against Avastin in bowel cancer forces Roche to turn to Cancer Drugs Fund.